Skip to Main Content

Author Details

Alex B Blair
Johns Hopkins University School of Medicine
2015
59
21
PMIDPaper TitleJournal TitlePublished Year
33811460Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study.J Hepatobiliary Pancreat Sci2023
35448929Proximal vs. Total Gastrectomy: Is There a Difference in Quality of Life for Patients?Am Surg2023
33201121Invasive and Noninvasive Progression After Resection of Noninvasive Intraductal Papillary Mucinous Neoplasms.Ann Surg2022
35437667The Role of Diffusion-Weighted Magnetic Resonance Imaging in Staging After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma: Reply.Ann Surg Oncol2022
35718227Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy.Gastroenterology2022
36306792Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy.Cancer Cell2022
36062077Geographic variation in attitudes regarding management of locally advanced pancreatic cancer.Surg Open Sci2022
34610896Should non-invasive diffuse main-duct intraductal papillary mucinous neoplasms be treated with total pancreatectomy?HPB (Oxford)2022
34448965Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.Ann Surg Oncol2022
31449138Management of Locally Advanced Pancreatic Cancer: Results of an International Survey of Current Practice.Ann Surg2021
33628595Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells.Cancer Biol Med2021
34467768CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.AJR Am J Roentgenol2021
34027578Proclivity to Explore Locally Advanced Pancreas Cancer Is Not Associated with Surgeon Volume.J Gastrointest Surg2021
33277370Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma.Clin Cancer Res2021
33271264CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma.Cancer Lett2021
33127389Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017.Cancer Lett2021
32912834Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma.HPB (Oxford)2021
32304375Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer.Ann Surg2021
30528925World Health Organization Surgical Safety Checklist Modification: Do Changes Emphasize Communication and Teamwork?J Surg Res2020
31685251Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.J Surg Res2020
33208887Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning.Sci Rep2020
32657929Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.Ann Surg2020
32675194Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer.J Immunother Cancer2020
32205000Coexisting Systemic Infections in Patients Hospitalized Because of a Fall: Prevalence and Risk Factors.J Emerg Med2020
32376802Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer.JCI Insight2020
29596120Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection.Ann Surg2019
30242644Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy.J Gastrointest Surg2019
29958227A Roadmap for Aspiring Surgeon-Scientists in Today's Healthcare Environment.Ann Surg2019
31441048Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10â¿¿mm or less.Br J Surg2019
31186314Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.Clin Cancer Res2019
31425483A Qualitative Review of Neoadjuvant Chemotherapy in Resectable Pancreatic Adenocarcinoma.Pancreas2019
30777697Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival.HPB (Oxford)2019
31032290Lessons learned by features of pancreatic ductal adenocarcinoma and its tumor microenvironment.Ann Transl Med2019
31113479Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.J Immunother Cancer2019
31082915Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.Ann Surg2019
31023560Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer.Eur J Surg Oncol2019
30747725IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma.J Clin Invest2019
29334562Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?Ann Surg2018
29855832Minimally Invasive Versus Open Primary Resection for Retroperitoneal Soft Tissue Sarcoma: A Propensity-Matched Study From the National Cancer Database.Ann Surg Oncol2018
29878363Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution.J Surg Oncol2018
29948425Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.Ann Surg Oncol2018
31179441Spleen-preserving distal pancreatectomy with splenic vessel preservation: challenges in measuring the learning curve.Laparosc Surg2018
30424804Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer.J Immunother Cancer2018
30380143Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma.J Surg Oncol2018
29363015Pancreaticoduodenectomy and Superior Mesenteric Vein Resection Without Reconstruction for Locally Advanced Pancreatic Cancer.J Gastrointest Surg2018
29501212Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.Curr Probl Cancer2018
29395234Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy.Surgery2018
29309945BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma.J Am Coll Surg2018
28818633Patient- and Caregiver-Reported Assessment Tools for Palliative Care: Summary of the 2017 Agency for Healthcare Research and Quality Technical Brief.J Pain Symptom Manage2017
28104099Coexisting Systemic Infections in Patients Who Present With a Fall.Am J Med Sci2017
  • 1 - 50 of 59

Recommended Authors

Sidney Kimmel Cancer Center at Thomas Jefferson University
Career Start Year 2017
Number of shared co-authors 2
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 2014
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
University of Colorado
Career Start Year 2014
Number of shared co-authors 2
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 0
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
University of California
Career Start Year 2007
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 2006
Number of shared co-authors 1
Tisch Cancer Institute, Mount Sinai Hospital
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
University of California San Diego
Career Start Year 2004
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Cancer Center Amsterdam
Career Start Year 2001
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
University of California san francisco
Career Start Year 1999
Number of shared co-authors 0
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
University of Cincinnati College of Medicine
Career Start Year 1996
Number of shared co-authors 0
Surgical Outcomes Research Center, University of Virginia
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 3
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 0
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 0
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 0
430482University of Tennessee Health Science Center
Career Start Year 1990
Number of shared co-authors 1
Dartmouth-Hitchcock Medical Center
Career Start Year 1990
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 3
University of California San Diego
Career Start Year 1985
Number of shared co-authors 1

Collaborators

Convergence Institute, Johns Hopkins University
Co-authored papers 7
University of Colorado
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Co-authored papers 1
Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health
Co-authored papers 1
Johns Hopkins University
Co-authored papers 1
Co-authored papers 1
Stanford University School of Medicine.
Co-authored papers 1
Samuel Oschin Cancer Center, Cedars Sinai Medical Center
Co-authored papers 1
University of California - Los Angeles
Co-authored papers 1
University of Washington
Co-authored papers 1
Wake Forest University
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
University of Colorado School of Medicine
Co-authored papers 1
Duke Cancer Center Cary
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1